Clinical implications of Brief Psychiatric Rating Scale scores
- PMID: 16199797
- DOI: 10.1192/bjp.187.4.366
Clinical implications of Brief Psychiatric Rating Scale scores
Abstract
Background: Despite the widespread use of the Brief Psychiatric Rating Scale (BPRS), the clinical meaning of its total score and cut-off values used to define treatment response are unclear.
Aims: To link the BPRS to Clinical Global Impression (CGI) ratings.
Method: Equipercentile linking of BPRS and CGI ratings from seven drug trials in acutely ill patients with schizophrenia (n=1979).
Results: 'Mildly ill' according to the CGI approximately corresponded to a BPRS total score of 31, 'moderately ill'to a BPRS score of 41 and'markedly ill'to a BPRS score of 53.'Minimally improved'according to the CGI score was associated with percentage BPRS reductions of 24, 27 and 30% at weeks 1, 2 and 4, respectively. The corresponding numbers for a CGI rating of 'much improved' were 44, 53 and 58%.
Conclusions: The results provide a clearer understanding of how to interpret BPRS total and percentage reduction scores in clinical trials with patients acutely ill with schizophrenia who are experiencing positive symptoms.
Similar articles
-
Linking the PANSS, BPRS, and CGI: clinical implications.Neuropsychopharmacology. 2006 Oct;31(10):2318-25. doi: 10.1038/sj.npp.1301147. Epub 2006 Jul 5. Neuropsychopharmacology. 2006. PMID: 16823384
-
Equipercentile linking of the Brief Psychiatric Rating Scale and the Clinical Global Impression Scale in a catchment area.Eur Neuropsychopharmacol. 2012 Jul;22(7):501-5. doi: 10.1016/j.euroneuro.2011.11.007. Epub 2012 Mar 3. Eur Neuropsychopharmacol. 2012. PMID: 22386773
-
Identifying clinically meaningful symptom response cut-off values on the SANS in predominant negative symptoms.Schizophr Res. 2013 Apr;145(1-3):125-7. doi: 10.1016/j.schres.2012.12.032. Epub 2013 Feb 8. Schizophr Res. 2013. PMID: 23394742 Clinical Trial.
-
Amisulpride: a review of its efficacy in schizophrenia.Acta Psychiatr Scand Suppl. 2000;400:17-22. Acta Psychiatr Scand Suppl. 2000. PMID: 10823307 Review.
-
Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia.Br J Psychiatry. 2011 Oct;199(4):275-80. doi: 10.1192/bjp.bp.110.083907. Br J Psychiatry. 2011. PMID: 22187729 Review.
Cited by
-
Non-dipping nocturnal blood pressure and psychosis parameters in Parkinson disease.Clin Auton Res. 2015 Apr;25(2):109-16. doi: 10.1007/s10286-015-0270-5. Epub 2015 Feb 18. Clin Auton Res. 2015. PMID: 25690741
-
The "delayed onset" of antipsychotic action--an idea whose time has come and gone.J Psychiatry Neurosci. 2006 Mar;31(2):93-100. J Psychiatry Neurosci. 2006. PMID: 16575424 Free PMC article. Review.
-
Single-Session Mobile-Augmented Intervention in Serious Mental Illness: A Three-Arm Randomized Controlled Trial.Schizophr Bull. 2019 Jun 18;45(4):752-762. doi: 10.1093/schbul/sby135. Schizophr Bull. 2019. PMID: 30281086 Free PMC article. Clinical Trial.
-
Clinical and Biological Factors Are Associated with Treatment-Resistant Depression.Behav Sci (Basel). 2022 Feb 3;12(2):34. doi: 10.3390/bs12020034. Behav Sci (Basel). 2022. PMID: 35200285 Free PMC article.
-
Psychosocial interventions for people with both severe mental illness and substance misuse.Cochrane Database Syst Rev. 2019 Dec 12;12(12):CD001088. doi: 10.1002/14651858.CD001088.pub4. Cochrane Database Syst Rev. 2019. PMID: 31829430 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical